Daniel H. Ahn
Impact in
Papers in
- Co-authors
- Tanios Bekaii‐Saab (109 shared papers)Glyn Johnson (2 shared papers)Stanley Lu (2 shared papers)Mitesh J. Borad (43 shared papers)Soonmee Cha (1 shared paper)Milind Javle (15 shared papers)Rachna T. Shroff (10 shared papers)Ahmed O. Kaseb (6 shared papers)
- Journals
- Journal of Clinical Oncology (45 papers)Annals of Oncology (11 papers)The Oncologist (10 papers)Cancer Research (5 papers)Cancer (5 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Daniel H. Ahn
145 papers receiving 3.8k citations
Daniel H. Ahn's Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 1.6k
- Surgery 1.3k
- Hepatology 233
- Cancer Research 408
- Genetics 271
Countries citing papers authored by Daniel H. Ahn
This map shows the geographic impact of Daniel H. Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel H. Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel H. Ahn more than expected).
Fields of papers citing papers by Daniel H. Ahn
This network shows the impact of papers produced by Daniel H. Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel H. Ahn. The network helps show where Daniel H. Ahn may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel H. Ahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 157 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers Hit paper breakdown → | 2019 | 337 |
| 2 | Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. | 2003 | 320 |
| 3 | Biliary cancer: Utility of next‐generation sequencing for clinical management Hit paper breakdown → | 2016 | 300 |
| 4 | 2004 | 273 | |
| 5 | 2019 | 196 | |
| 6 | 2020 | 143 | |
| 7 | 2018 | 128 | |
| 8 | 2016 | 124 | |
| 9 | 2015 | 105 | |
| 10 | 2017 | 92 | |
| 11 | 2014 | 78 | |
| 12 | 2015 | 73 | |
| 13 | 2019 | 73 | |
| 14 | 2015 | 63 | |
| 15 | 2019 | 63 | |
| 16 | 2019 | 56 | |
| 17 | 2018 | 54 | |
| 18 | 2013 | 52 | |
| 19 | 2017 | 49 | |
| 20 | Mice deficient for N-ras: impaired antiviral immune response and T-cell function. | 2003 | 47 |
About Daniel H. Ahn
Daniel H. Ahn is a scholar working on Oncology, Surgery, Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 157 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (48 papers), Pancreatic and Hepatic Oncology Research (36 papers), Cancer Genomics and Diagnostics (32 papers), Colorectal Cancer Treatments and Studies (31 papers), Cancer Treatment and Pharmacology (14 papers), Genetic factors in colorectal cancer (12 papers), Fibroblast Growth Factor Research (10 papers) and Cancer Immunotherapy and Biomarkers (10 papers). The work is most often cited by research in Oncology (1.6k citations), Surgery (1.3k citations), Hepatology (233 citations), Cancer Research (408 citations) and Genetics (271 citations). Daniel H. Ahn has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Tanios Bekaii‐Saab, Glyn Johnson, Stanley Lu, Mitesh J. Borad, Soonmee Cha, Milind Javle, Rachna T. Shroff, Ahmed O. Kaseb, Mohamad Bassam Sonbol and Robert I. Grossman. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Oncologist, Cancer Research and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.